Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker APG
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Nov 9, 2026 | James E. Lillie Director | APG APi Group Corporation | 375,000 | $15.3M | 10b5-1 | Nov 9, 2026 | Form 4 ↗ 3 days later · 349,999 shares | Form 144 ↗ |
| Aug 3, 2026 | James E. Lillie Director | APG APi Group Corporation | 375,000 | $14.9M | 10b5-1 | Aug 3, 2026 | Form 4 ↗ 2 days later · 360,000 shares | Form 144 ↗ |
| Aug 3, 2026 | Ian G. H. Ashken Director | APG APi Group Corporation | 300,000 | $11.9M | 10b5-1 | Aug 3, 2026 | Form 4 ↗ 2 days later · 300,000 shares | Form 144 ↗ |
| Jun 11, 2026 | MEF Holdings, LLLP Director | APG APi Group Corporation | 2.00M | $85.3M | — | Jun 11, 2026 | — | Form 144 ↗ |
| Mar 19, 2026 | MEF Holdings, LLLP Director | APG APi Group Corporation | 3.00M | $123.6M | — | Mar 19, 2026 | — | Form 144 ↗ |
| Mar 2, 2026 | James E. Lillie Director | APG APi Group Corporation | 750,000 | $33.3M | 10b5-1 | Mar 2, 2026 | Form 4 ↗ 2 days later · 360,000 shares | Form 144 ↗ |
| Mar 2, 2026 | Ian G. H. Ashken Director | APG APi Group Corporation | 534,000 | $23.7M | 10b5-1 | Mar 2, 2026 | Form 4 ↗ 2 days later · 300,000 shares | Form 144 ↗ |
| Feb 27, 2026 | Glenn David Jackola Officer | APG APi Group Corporation | 18,000 | $796.1K | — | Feb 27, 2026 | Form 4 ↗ 4 days later · 18,000 shares | Form 144 ↗ |
| Feb 26, 2026 | Louis Lambert Officer | APG APi Group Corporation | 22,000 | $983.5K | — | Feb 26, 2026 | Form 4 ↗ same day · 22,000 shares | Form 144 ↗ |
| Nov 3, 2025 | MEF Holdings, LLLP Shareholder | APG APi Group Corporation | 900,000 | $32.2M | 10b5-1 | Nov 3, 2025 | — | Form 144 ↗ |
| Sep 2, 2025 | MEF Holdings, LLLP Shareholder | APG APi Group Corporation | 1.20M | $41.6M | 10b5-1 | Sep 2, 2025 | — | Form 144 ↗ |
| Aug 12, 2025 amended | Ian G. H. Ashken Director | APG APi Group Corporation | 225,000 | $7.8M | 10b5-1 | Aug 11, 2025 | Form 4 ↗ 1 day later · 225,000 shares | Form 144/A ↗ |
| Aug 12, 2025 amended | James E. Lillie Director | APG APi Group Corporation | 375,000 | $12.9M | 10b5-1 | Aug 11, 2025 | Form 4 ↗ 1 day later · 360,000 shares | Form 144/A ↗ |
| Aug 11, 2025 | Ian G. H. Ashken Director | APG APi Group Corporation | 150,000 | $5.2M | 10b5-1 | Aug 11, 2025 | Form 4 ↗ 2 days later · 225,000 shares | Form 144 ↗ |
| Aug 11, 2025 | James E. Lillie Director | APG APi Group Corporation | 250,000 | $8.6M | 10b5-1 | Aug 11, 2025 | Form 4 ↗ 2 days later · 360,000 shares | Form 144 ↗ |
| Aug 4, 2025 | Arseniadis James Officer | APG APi Group Corporation | 4,843 | $171.3K | — | Aug 4, 2025 | Form 4 ↗ 1 day later · 4,843 shares | Form 144 ↗ |
| May 2, 2025 | Louis Lambert Officer | APG APi Group Corporation | 7,096 | $292.6K | — | May 2, 2025 | Form 4 ↗ 4 days later · 7,096 shares | Form 144 ↗ |
| Mar 3, 2025 | James E. Lillie Director | APG APi Group Corporation | 500,000 | $19.6M | 10b5-1 | Mar 3, 2025 | Form 4 ↗ 2 days later · 250,000 shares | Form 144 ↗ |
| Mar 3, 2025 | Ian G. H. Ashken Director | APG APi Group Corporation | 350,000 | $13.7M | 10b5-1 | Mar 3, 2025 | Form 4 ↗ 2 days later · 200,000 shares | Form 144 ↗ |
| Nov 12, 2024 | James E. Lillie Director | APG APi Group Corporation | 250,000 | $9.3M | 10b5-1 | Nov 11, 2024 | Form 4 ↗ 1 day later · 190,076 shares | Form 144 ↗ |
| Nov 12, 2024 | Ian G. H. Ashken Director | APG APi Group Corporation | 200,000 | $7.4M | 10b5-1 | Nov 11, 2024 | Form 4 ↗ 1 day later · 146,132 shares | Form 144 ↗ |
| Nov 4, 2024 | MEF Holdings, LLLP Shareholder | APG APi Group Corporation | 660,000 | $23.4M | 10b5-1 | Nov 4, 2024 | — | Form 144 ↗ |
| Aug 26, 2024 | Louis Lambert Officer | APG APi Group Corporation | 5,679 | $204.7K | 10b5-1 | Aug 26, 2024 | — | Form 144 ↗ |
| Aug 21, 2024 | MEF Holdings, LLLP Shareholder | APG APi Group Corporation | 660,000 | $23.2M | 10b5-1 | Aug 21, 2024 | — | Form 144 ↗ |
| Aug 5, 2024 | James E. Lillie Director | APG APi Group Corporation | 125,000 | $4.1M | 10b5-1 | Aug 5, 2024 | — | Form 144 ↗ |
| Aug 5, 2024 | Ian G. H. Ashken Director | APG APi Group Corporation | 150,000 | $4.9M | 10b5-1 | Aug 5, 2024 | — | Form 144 ↗ |
| Aug 5, 2024 | Louis Lambert Officer | APG APi Group Corporation | 6,333 | $205.5K | 10b5-1 | Aug 5, 2024 | — | Form 144 ↗ |
| Jun 10, 2024 | MEF Holdings, LLLP Shareholder | APG APi Group Corporation | 660,000 | $24.9M | 10b5-1 | Jun 10, 2024 | — | Form 144 ↗ |
| Mar 4, 2024 | James E. Lillie Director | APG APi Group Corporation | 250,000 | $9.4M | 10b5-1 | Mar 4, 2024 | — | Form 144 ↗ |
| Mar 4, 2024 | Ian G. H. Ashken Director | APG APi Group Corporation | 300,000 | $11.3M | 10b5-1 | Mar 4, 2024 | — | Form 144 ↗ |
| Jan 2, 2024 | Viking Global Investors LP 10% Stockholder | APG APi Group Corporation | 6.50M | $213.7M | — | Jan 2, 2024 | — | Form 144 ↗ |
| Nov 7, 2023 amended | James E. Lillie Director | APG APi Group Corporation | 166,666 | $4.6M | 10b5-1 | Nov 6, 2023 | — | Form 144/A ↗ |
| Nov 7, 2023 amended | Ian G. H. Ashken Director | APG APi Group Corporation | 166,666 | $4.6M | 10b5-1 | Nov 6, 2023 | — | Form 144/A ↗ |
| Nov 7, 2023 | Juno Lower Holdings L.P. See Remarks | APG APi Group Corporation | 306,036 | $8.5M | — | Nov 7, 2023 | — | Form 144 ↗ |
| Nov 7, 2023 | FD Juno Holdings L.P. See Remarks | APG APi Group Corporation | 3,816 | $105.5K | — | Nov 7, 2023 | — | Form 144 ↗ |
| Nov 6, 2023 | Ian G. H. Ashken Director | APG APi Group Corporation | 166,666 | $4.6M | 10b5-1 | Nov 6, 2023 | — | Form 144 ↗ |
| Nov 6, 2023 | James E. Lillie Director | APG APi Group Corporation | 166,666 | $4.6M | 10b5-1 | Nov 6, 2023 | — | Form 144 ↗ |
| Aug 14, 2023 | FD Juno Holdings L.P. 10% Stockholder | APG APi Group Corporation | 32,004 | $889.7K | — | Aug 14, 2023 | — | Form 144 ↗ |
| Aug 14, 2023 | Juno Lower Holdings L.P. 10% Stockholder | APG APi Group Corporation | 2.57M | $71.4M | — | Aug 14, 2023 | — | Form 144 ↗ |
| Jun 1, 2023 | Ian G. H. Ashken Director | APG APi Group Corporation | 333,334 | $7.5M | 10b5-1 | Jun 1, 2023 | — | Form 144 ↗ |
| Jun 1, 2023 | James E. Lillie Director | APG APi Group Corporation | 333,334 | $7.5M | 10b5-1 | Jun 1, 2023 | — | Form 144 ↗ |
41 items, most recent first (up to 50). Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 6:54 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances